公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile | Lin T.-C.; Jiang S.-S.; WEN-CHIEN CHOU ; HSIN-AN HOU ; Lin Y.-M.; Chang C.-L.; Hsu C.-A.; HWEI-FANG TIEN ; LIANG-IN LIN | Journal of Molecular Diagnostics | 13 | 13 | |
2016 | Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation | YUN CHIANG ; CHENG-HONG TSAI ; SUNG-HSIN KUO ; Liu, Chieh-Yu; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; Lin, Chien-Ting; HSIN-AN HOU ; WEN-CHIEN CHOU ; JIA-HAU LIU ; CHIEN-CHIN LIN ; SHANG-JU WU ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; YUNG-LI YANG ; HSIU-HAO CHANG ; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; SHENG-CHIEH CHOU ; Chieh-Lung Cheng ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN ; JIH-LUH TANG ; YU-HSUAN CHEN | Scientific Reports | 18 | 15 | |
2009 | Reply to Heterogeneity within AML with CEBPA mutations; Only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis | HSIN-AN HOU ; LIANG-IN LIN ; Chen, Chien-Yuan ; HWEI-FANG TIEN | British Journal of Cancer | 24 | 22 | |
2022 | Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias | Su, Kuan-Wei; DA-LIANG OU ; Fu, Yu-Hsuan; HWEI-FANG TIEN ; HSIN-AN HOU ; LIANG-IN LIN | Cancer Gene Therapy | 3 | 2 | |
2024 | Response to letter to the editor "Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015" | Tsai, Xavier Cheng-Hong; HSIN-AN HOU | Journal of the Formosan Medical Association = Taiwan yi zhi | | | |
2015 | Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults | Chieh-Lung Cheng ; Li, Chi-Cheng; HSIN-AN HOU ; Fang, Wei-Quan; Chang, Chin-Hao; Lin, Chien-Ting; JIH-LUH TANG ; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | BMC cancer | 42 | 40 | |
2023 | Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial | Zeidan, Amer M; Ando, Kiyoshi; Rauzy, Odile; Turgut, Mehmet; Wang, Ming-Chung; Cairoli, Roberto; HSIN-AN HOU ; Kwong, Yok-Lam; Arnan, Montserrat; Meers, Stef; Pullarkat, Vinod; Santini, Valeria; Malek, Kamel; Kiertsman, Flavia; Niolat, Julie; Ramos, Pedro Marques; Menssen, Hans D; Fenaux, Pierre; Miyazaki, Yasushi; Platzbecker, Uwe | The Lancet. Haematology | 3 | 0 | |
2011 | Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information | WEN-CHIEN CHOU ; HSIN-AN HOU ; Liu C.-Y.; Chen C.-Y.; LIANG-IN LIN ; Huang Y.-N.; Chao Y.-C.; Hsu C.-A.; Huang C.-F.; HWEI-FANG TIEN | Annals of Oncology | 34 | 30 | |
2015 | SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS | Inoue D.; Kitaura J.; Matsui H.; HSIN-AN HOU ; WEN-CHIEN CHOU ; Nagamachi A.; Kawabata K.C.; Togami K.; Nagase R.; Horikawa S.; Saika M.; Micol J.-B.; Hayashi Y.; Harada Y.; Harada H.; Inaba T.; HWEI-FANG TIEN ; Abdel-Wahab O.; Kitamura T. | Leukemia | 63 | 56 | |
2014 | SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; SHANG-JU WU ; Liu C.-Y.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; SZU-CHUN HSU ; BOR-SHENG KO ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 30 | 26 | |
2023 | Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia | Sahoo, Binay K; Lin, Yuh-Charn; Tu, Cheng-Fen; CHIEN-CHIN LIN ; Liao, Wei-Ju; Li, Fu-An; Li, Ling-Hui; Mou, Kurt Yun; Roffler, Steve R; Wang, Shu-Ping; Yeh, Chi-Tai; CHI-YUAN YAO ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Yang, Ruey-Bing | Haematologica | 2 | 1 | |
2016 | Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma | SHANG-YI HUANG ; Lin, Hsiu-Hsia; CHUNG-WU LIN ; Li, Chi-Cheng; MING YAO ; JIH-LUH TANG ; HSIN-AN HOU ; WOEI TSAY ; Chou, Sheng-Je; Chieh-Lung Cheng ; HWEI-FANG TIEN | Oncotarget | 26 | 26 | |
2022 | Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes | McLemore, Amy F; HSIN-AN HOU ; Meyer, Benjamin S; Lam, Nghi B; Ward, Grace A; Aldrich, Amy L; Rodrigues, Matthew A; Vedder, Alexis; Zhang, Ling; Padron, Eric; Vincelette, Nicole D; Sallman, David A; Abdel-Wahab, Omar; List, Alan F; McGraw, Kathy L | JCI insight | 12 | 10 | |
2016 | Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia | HSIN-AN HOU ; Liu, Chieh-Yu; Kuo, Yuan-Yeh; WEN-CHIEN CHOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; LIANG-IN LIN ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; JIH-LUH TANG ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, Chien-Ting; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Oncotarget | 67 | 62 | |
2024 | Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities | WANG-DA LIU ; HSIN-AN HOU ; KO-JEN LI ; Qin, Albert; Tsai, Chan-Yen; WANG-HUEI SHENG | Advances in therapy | 0 | 0 | |
2022 | SURPASS-ET: phase III study of ropeginterferon alfa-2b versus anagrelide as second-line therapy in essential thrombocythemia | Verstovsek, Srdan; Komatsu, Norio; Gill, Harinder; Jin, Jie; Lee, Sung-Eun; HSIN-AN HOU ; Sato, Toshiaki; Qin, Albert; Urbanski, Raymond; Shih, Weichung; Zagrijtschuk, Oleh; Zimmerman, Craig; Mesa, Ruben A | Future oncology (London, England) | 20 | 11 | |
2011 | TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics | WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; HSIN-AN HOU ; Kuo Y.-Y.; Lee M.-C.; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 255 | 235 | |
2021 | TFEB Links MYC Signaling to Epigenetic Control of Myeloid Differentiation and Acute Myeloid Leukemia | Yun S.; Vincelette N.D.; Yu X.; Watson G.W.; Fernandez M.R.; Yang C.; Hitosugi T.; Cheng C.-H.; Freischel A.R.; Zhang L.; Li W.; HSIN-AN HOU ; Schaub F.X.; Vedder A.R.; Cen L.; McGraw K.L.; Moon J.; Murphy D.J.; Ballabio A.; Kaufmann S.H.; Berglund A.E.; Cleveland J.L. | Cancer discovery | 20 | 16 | |
2023 | A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia | Wang, Yu-Hung; CHI-YUAN YAO ; CHIEN-CHIN LIN ; Gurashi, Kristian; Amaral, Fabio M R; Bossenbroek, Hasse; Jerez, Andres; Somervaille, Tim C P; Binder, Moritz; Patnaik, Mrinal M; HSIN-AN HOU ; WEN-CHIEN CHOU ; Batta, Kiran; Wiseman, Daniel H; HWEI-FANG TIEN | British journal of haematology | 0 | 0 | |
2015 | TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution | HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo, Y.-Y.; Liu, C.-Y.; LIANG-IN LIN ; Tseng, M.-H.; Chiang, Y.-C.; Liu, M.-C.; Liu, C.-W.; JIH-LUH TANG ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood Cancer Journal | 112 | 111 | |